AMYRIS, Inc. (AMRS) Reports Q2 Loss of 95c/Share
AMYRIS, Inc. (NASDAQ: AMRS) reported Q2 EPS of ($0.95), $0.37 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $32 million versus the consensus estimate of $41.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amyris (AMRS) Announces Development of Yeast Strain Ready for Industrial Scale Fermentation in Less Than 12 Months
- Mitcham Industries (MIND) Reports Q2 Loss Per Share of $0.49
- Amyris Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready for Industrial Scale Fermentation in Less Than 12 Months
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!